ultra-hypofractionated radiotherapy

RADIATION2 trials

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Royal Surrey County Hospital NHS Foundation Trust

Conditions

Prostate AdenocarcinomaRadiotherapy Side EffectRetroperitoneal SarcomaSoft Tissue SarcomaStereotactic Ablative RadiotherapyUltra-hypofractionated Radiotherapy

Unknown Phase

Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)

RecruitingNCT05224934

Cancer Institute and Hospital, Chinese Academy of Medical SciencesRadiotherapy Side Effect, Retroperitoneal Sarcoma, Soft Tissue Sarcoma +2

Start: 2022-01-01End: 2027-12-31Target: 50Updated: 2025-12-11

Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer

Not yet recruitingNCT07210502

Royal Surrey County Hospital NHS Foundation TrustProstate Adenocarcinoma

Start: 2025-12-01End: 2030-12-01Target: 220Updated: 2025-10-07

Related Papers

The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer.

2026-04-27